In 3 seven night time, double-blind, parallel-group trials comparing Estazolam 1 mg and/or two mg with placebo in adult outpatients with Persistent sleeplessness, Estazolam two mg was continuously remarkable to placebo in subjective measures of slumber induction (latency) and snooze maintenance (duration, amount of awakenings, depth and high-qualit